# AI-Assisted Adaptive Clinical Trial for Early Treatment Failure in Type 2 Diabetes

## ğŸ“Œ Project Overview

This project presents an **AI-assisted adaptive clinical trial framework** designed to identify and respond to **early treatment failure in patients with Type 2 Diabetes Mellitus (T2DM)**. The study integrates **machine learningâ€“based risk prediction**, **adaptive trial design**, and **real-world data simulation** to improve personalized treatment decision-making and trial efficiency.

Traditional clinical trials in diabetes often rely on static treatment allocation and population-level outcomes. This project demonstrates how **artificial intelligence can be embedded within an adaptive trial framework** to dynamically stratify risk, guide treatment adjustments, and compare outcomes between conventional and AI-adaptive trial arms.

---

## ğŸ¯ Objectives

The project is guided by the following objectives:

1. **To develop an AI-driven framework** for predicting early treatment failure in Type 2 Diabetes.
2. **To simulate and compare** outcomes between a conventional control trial arm and an AI-adaptive intervention arm.
3. **To evaluate clinical outcomes and trial efficiency**, including failure rates and risk stratification performance.

---

## ğŸ§  Methodology

* **Study Design:** Simulated adaptive clinical trial
* **Data:** Synthetic dataset representing 1,000 participants with Type 2 Diabetes
* **Features:** Clinical variables, behavioral indicators, and simulated wearable-derived metrics
* **Modeling Approach:** Machine learning classification for early treatment failure prediction
* **Trial Arms:**

  * Conventional control arm (static treatment)
  * AI-adaptive arm (risk-based treatment adjustment)

The adaptive framework uses model-predicted risk levels to guide treatment escalation or optimization during the simulated trial.

---

## ğŸ“Š Key Components

* Data preprocessing and feature engineering
* Machine learning model development and evaluation
* Risk stratification (low, moderate, high risk)
* Adaptive treatment allocation logic
* Comparative analysis of trial outcomes

---

## ğŸ—‚ï¸ Repository Structure

```
ClinicalTrials.github/
â”‚
â”œâ”€â”€ AI-Assisted Adaptive Clinical Trial for Early Treatment Failure in Type 2 Diabetes.ipynb
â”œâ”€â”€ README.md
â”œâ”€â”€ data/                # (Optional) datasets or synthetic data
â”œâ”€â”€ figures/             # (Optional) plots and visual outputs
â””â”€â”€ docs/                # (Optional) reports or manuscripts
```

---

## ğŸ› ï¸ Tools and Technologies

* Python
* Jupyter Notebook
* Pandas
* NumPy
* Scikit-learn
* Matplotlib / Seaborn

---

## ğŸ“ˆ Expected Outcomes

* Improved identification of patients at risk of early treatment failure
* Reduced failure rates in the AI-adaptive trial arm
* Demonstration of the feasibility of integrating AI into adaptive clinical trial designs
* Contribution to precision medicine and data-driven clinical research

---

## âš ï¸ Disclaimer

This project is **for academic and research purposes only**.
The data used are **synthetic** and do not represent real patients.
The framework is **not intended for direct clinical use** without proper validation and regulatory approval.

---

## ğŸ‘¤ Author

**Chrispine Buxtone Ooko**
Applied Statistics / Data Science
AI-Assisted Clinical Trial Research

---

## ğŸ“„ License

This project is released under the **MIT License** (or update as appropriate).

---


